Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 1.25M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 1.25M | -- |
| Cost of Revenue | -- | -- | -- | 3.38M | -- |
| Gross Profit | -- | -- | -- | -2.13M | -- |
| SG&A Expenses | -- | -- | -- | 2.65M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 9.16M | -- |
| Operating Income | -- | -- | -- | -7.92M | -- |
| Income Before Tax | -- | -- | -- | -8.45M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -8.45 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -8.45M | -- |
| EBIT | -- | -- | -- | -7.92M | -- |
| EBITDA | -- | -- | -- | -6.35M | -- |
| EPS Basic | -- | -- | -- | -2.56M | -- |
| Normalized Basic EPS | -- | -- | -- | -91.78 | -- |
| EPS Diluted | -- | -- | -- | -2.56M | -- |
| Normalized Diluted EPS | -- | -- | -- | -91.78 | -- |
| Average Basic Shares Outstanding | -- | -- | -- | 3.61M | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | 600.00 | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |